Medicine

All Articles

Human outbreaks of an unique reassortant Oropouche infection in the Brazilian Amazon area

.Attribute Medication, Posted online: 18 September 2024 doi:10.1038/ s41591-024-03300-3Genomic and e...

Neoadjuvant nivolumab or even nivolumab plus ipilimumab in early-stage triple-negative bosom cancer: a phase 2 flexible test

.PatientsPatients in associates An and B were actually eligible for enrollment if they were at minim...

Targeted therapy directed by flowing cyst DNA review in enhanced stomach lumps

.Nature Medication, Released online: 16 September 2024 doi:10.1038/ s41591-024-03244-8In the observa...

Countering the impact of the climate situation on wellness are going to demand data

.As substantially rising worldwide temps intimidate the wellness and also well-being of populations,...

Exposure to harsh heat boosts perinatal mortality in sub-Saharan Africa

.Publisheru00e2 $ s take note Springer Attribute continues to be neutral when it come to administrat...

Data- driven threat stratification and also precision administration of pulmonary nodules spotted on upper body figured out tomography

.Attendee recruitmentThe retrospective main dataset comprised attendees coming from the MCC in the W...

Datopotamab\u00e2 $ \"deruxtecan in early-stage boob cancer: the consecutive multiple assignment randomized I-SPY2.2 period 2 test

.Competing rate of interests.J.L.M. discloses institutional analysis funding coming from AstraZeneca...

Trastuzumab deruxtecan in HER2-positive state-of-the-art breast cancer cells along with or without brain metastases: a stage 3b\/4 trial

.Nature Medication, Released online: thirteen September 2024 doi:10.1038/ s41591-024-03261-7In the n...

Advancing ASO therapies from advancement to execution

.Contending passions.R.S., M.S., H.G. as well as A.A.R. are actually coordinators of the 1M1M projec...

Post- approval evidence creation: a common duty for healthcare

.Nature Medicine, Released online: 13 September 2024 doi:10.1038/ s41591-024-03241-xPost-approval do...